Cachexia: prevalence and impact in medicine
Authors:
- Kenneth Ch FearonKFKenneth Ch Fearon
- 1 July 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 11 (4) , 400-407
Abstract
Cachexia is a progressive deterioration of body habitus associated with certain chronic diseases (e.g., cancer, chronic obstructive pulmonary disease, chronic heart failure, and chronic kidney disease). The aim of this article is to describe the prevalence and impact of cachexia (and precachexia) in such patients. Owing to the wide spectrum of clinical presentation and lack of an 'all-inclusive' definition, it is difficult to estimate the true prevalence of cachexia. Perhaps 2% of the population suffer from precachexia (characterized by weight loss in association with a chronic disease). The significant increase in obesity of the general population (which can mask significant muscle wasting) confounds such simple estimates of the true prevalence of cachexia. In contrast, a multidimensional characterization of the cachectic state (including weight loss, reduced food intake, and systemic inflammation) may be more meaningful in terms of altered clinical outcomes. Such a multidimensional view of cachexia has been shown to impact on patients' survival and quality of life and therefore constitutes a major public health issue. There is a high prevalence of (pre)cachexia in patients with chronic diseases. The cachexia syndrome is probably less frequent but has a significant impact in terms of morbidity and mortality.Keywords
This publication has 38 references indexed in Scilit:
- Heart failure and cachexia: insights offered from molecular biologyFrontiers in Bioscience-Landmark, 2008
- Pathophysiology of cancer cachexia: Much more than host–tumour interaction?Clinical Nutrition, 2007
- Daily Physical-Rest Activities in Relation to Nutritional State, Metabolism, and Quality of Life in Cancer Patients with Progressive CachexiaClinical Cancer Research, 2007
- Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancerBritish Journal of Surgery, 2007
- Cachexia in chronic kidney disease: role of inflammation and neuropeptide signalingCurrent Opinion in Nephrology and Hypertension, 2007
- The costs of fatal and non-fatal falls among older adultsInjury Prevention, 2006
- Acute effect of oral steroids on muscle function in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2004
- Protein-energy malnutrition and involuntary weight loss: nutritional and pharmacological strategies to enhance wound healingExpert Opinion on Pharmacotherapy, 2003
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Prognostic effect of weight loss prior tochemotherapy in cancer patientsThe American Journal of Medicine, 1980